Author:
Longuespée Rémi,Boyon C.,Desmons Annie,Vinatier Denis,Leblanc Eric,Farré Isabelle,Wisztorski Maxence,Ly Kévin,D’Anjou François,Day Robert,Fournier Isabelle,Salzet Michel
Publisher
Springer Science and Business Media LLC
Reference220 articles.
1. Longuespée RB, C., Kerdraon, O., Vinatier, D., Fournier, I., Day, R., Salzet, M. (2012). MALDI MSI and Ovarian cancer Biomarkers. Advances in Cancer Management; Ed R. Mohan, Chap. 10, 211–236.
2. Jelovac, D., Armstrong, D.K. Recent progress in the diagnosis and treatment of ovarian cancer. CA: A Cancer Journal for Clinicians, 61, 183–203.
3. Konishi, H., Mohseni, M., Tamaki, A, et al. 2011. Mutation of a single allele of the cancer susceptibility gene BRCA1 leads to genomic instability in human breast epithelial cells. Proceedings of the National Academy of Sciences of the United States of America, 108, 17773–17778.
4. Saunders, K.H., Nazareth, S., Pressman, P.I. (2011). Case report: BRCA in the Ashkenazi population: are current testing guidelines too exclusive? Heredity Cancer Clinical Practice, 9(1), 3.
5. Jazaeri, A. A. (2009). Molecular profiles of hereditary epithelial ovarian cancers and their implications for the biology of this disease. Molecular Oncology, 3, 151–156.
Cited by
53 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献